TIMBERLYNE THERAPEUTICS Trademark
Trademark Overview
On Wednesday, November 6, 2024, a trademark application was filed for TIMBERLYNE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the TIMBERLYNE THERAPEUTICS trademark a serial number of 98839360. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Monday, April 6, 2026. This trademark is owned by Timberlyne Therapeutics Inc.. The TIMBERLYNE THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Pharmaceutical research and development
General Information
| Serial Number | 98839360 |
| Word Mark | TIMBERLYNE THERAPEUTICS |
| Filing Date | Wednesday, November 6, 2024 |
| Status | 748 - STATEMENT OF USE - TO EXAMINER |
| Status Date | Monday, April 6, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, June 10, 2025 |
Trademark Statements
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "THERAPEUTICS" |
| Description of Mark | The mark consists of "TIMBERLYNE THERAPEUTICS" with the "Y" formed by the stylized molecular model of an antibody. |
| Pseudo Mark | TIMBERLINE THERAPEUTICS |
| Goods and Services | Pharmaceutical research and development |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 6, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, January 9, 2025 |
| First Use In Commerce Date | Thursday, January 9, 2025 |
Trademark Owner History
| Party Name | Timberlyne Therapeutics Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92122
US |
| Party Name | Timberlyne Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92122
US |
Trademark Events
| Event Date | Event Description |
| Wednesday, November 6, 2024 | NEW APPLICATION ENTERED |
| Friday, March 7, 2025 | LETTER OF PROTEST EVIDENCE FORWARDED |
| Friday, May 2, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, May 5, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, May 7, 2025 | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN |
| Thursday, May 8, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, May 8, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 8, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 8, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, May 8, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 4, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 10, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 10, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 7, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, October 8, 2025 | TEAS STATEMENT OF USE RECEIVED |
| Friday, April 3, 2026 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, October 8, 2025 | USE AMENDMENT FILED |
| Monday, April 6, 2026 | STATEMENT OF USE PROCESSING COMPLETE |
